Skip to content

A cohort study on the effect of Tibetan medicine twenty-five-wei coral pill and Ruyi Zhenbao Pill on the recovery of neurological function after cerebral infarction

Study on the inheritance of Cardiovascular and Cerebrovascular Clinical and ethnic Medical techniques and the Development of New drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004073
Enrollment
Unknown
Registered
2020-11-23
Start date
2020-11-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

Sponsors

The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 56 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years old; 2. Meet the above diagnostic criteria of acute, convalescent and Tibetan medicine classification of cerebral infarction; 3. The vital signs are stable, conscious and able to express; 4. Be able to use mobile phone terminals or family members to cooperate with the use of evaluation; 5. Sign an informed consent form and agree to participate in this study; only those who meet the above five items can be selected.

Exclusion criteria

Exclusion criteria: 1. Suffer from other serious somatic diseases, such as malignant tumor, severe infection, multiple organ failure, etc. 2.Patients with unstable vital signs; 3. Those with severe aphasia and agnosia are unable to communicate; 4. A person who is known to be alcoholic or materially dependent; 5. Patients with severe hepatic and renal insufficiency; those who meet one of the above items shall be excluded.

Design outcomes

Primary

MeasureTime frame
mRS Scale;NIHSS Scale;Tibetan medicine scale;

Countries

China

Contacts

Public ContactSun Wenjun

The third affiliated Hospital of Beijing University of traditional Chinese Medicine

doctorsunwenjun@126.com+86 18910259376

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026